Autoimmune diseases of the nervous system
Keywords:
autoantibody, autoimmune diseases, myasthenia gravis, inflammatory neuropathy, multiple sclerosisAbstract
As a growing number of report suggests that neurologic diseases have a autoimmune basis, phisicians are confronted with new issues in diagnosis and treatment. At the sarne time, our understanding of antibody-induced neurologic disorders as been characterized in lhe last decade by an increasing knowledge of the molecular specificities of autoantibodies. This review summarizes some current concepts in autoimmune diseases of the nervous system.
Downloads
References
Drachman D. Myasthenia Gravis. ln J sselbacher, Braunwald, Wilson, Martin, Fauci, Kasper, eds, Harrison's Principies of Internai Medicine, 13th edition, pp 2393-2396, McGraw-Hill, Inc, 1994.
Oostherhuis H, Kuks J. Myasthenia Gravis and Myasthenic Syndromes. Curr Opin Neurol Neurosurg 1992; 5: 638-644.
Eymard B, Berrih AS. Rôle du Timus dans la Physiopathologie de la Myasthenie. Rev Neurol 1995; 151: 6-15.
Sreck A. Antibodies in the Neurology Clinic. Neurology 1990; 40: 1489-1492.
Kuks J, Limburg P, Horst G, et al. Antibodies to Skeletal Muscle in Myasthenia Gravis. Part 1. Diagnostic Value for the Detection of Timoma . J Neurol Sci 1993; 119: 183-188.
Kuks J, Limburg P, f-Jorst G, Oostherhuis H. Antibodies to Skeletal Muscle in Myasthenia Gravis. Part 2. Prevalence in non Thymoma Patients. J Neurol Sci 1993; 120: 78-81.
Kuks J, Limburg P, Horst G, Oostherhuis H. Antibodies to Skeletal Muscle in Myasthenia Gravis. Part 3. Relation With Clinical Course and Therapy. J Neurol Sci 1993; 120: 168-173.
Steck A: lnflammatory Neuropathy. Pathogenesis and Clinical Features. Curr Opin Neurol Neurosurg 1992; 5: 633-637.
Steck A, Kappos L. Gangliosides and Autoimmune Neuropathies. Classification and Clinical Aspects of Autoimmune Neuropathies. J Neur Neurosurg Psych 1994; (Suppl.) 57: 26-28.
llyas A, Mithen F, Chen Z, Cook S. Search for Antibodies to Neural Glycolipids in Séra of Patients with Guillain-Barré Syndrome. J Neuroç Sci 1991; 102: 67-75.
Fredman P, Vedeler C, Nyland H, et al. Antibodies in Sera from Patients with lnflammatory Demyelinating l'olyradiculoneuropathy React with Ganglioside LMl and Sulphatide of Peripheral Nerve Myelin. J Neural 1991 ; 238 75-79.
Simone I, Annunziata P, Maimone D, et al. Serum and CSF anti-GMJ antibodies in Patients with Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy. J Neural Sei 1993; 114: 49-55
Steck A, Murray N, Dellagi K, et al. Peripheral Neuropathy Associated with Monoclonal lgM Autoantibody. Ann Neurol 1987; 22: 764-767.
Hauser S. Multiple Sclerosis and other Demyelinaring Diseases. ln Jsselbacher, Braunwald, Wilson, Maltin, Fauci, Kasper, eds, Harrison's Principies of Internal Medicine, 13th edition, pp 2287-2295, McGraw-Hill, Jnc, 1994
Olsson T. Immunology of Multi pie Sclerosis. Curr Opin Neural Neurosurg 1992; 5: 195-202.
Ransohoff R, Tuohy V, Lehmann P. The Immunology oi Multi pie Sclerosis: New lntricacies and New lnsights. Curr Opin Neural 1994; 7: 242-249
Hohlfeld R, Meinl E, Weber F, et al. The Role of Autoimmune T Lymphocytes in the Pathogenesis of Multiple Sclerosis. Neu rology 1995; 45 (suppl 6): S33-S38.
Warren K, Catz I, Johnson E, Mielke B. Anti-Myelin Basic Protein and Anti-Proteolipid Protein Specific Fonns of Multiple Sclerosis. Ann Neurol 1994; :35: 280-289.
Faulds D, Benfield P. lnterferon beta-ib in Multiple Sclerosis. An lnitial Review of its Rational Use and Therapeutic Potential. Clin Immunother 1994; 1: 79-87.
Additional Files
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna
Open Access
